Skip to main navigation Skip to search Skip to main content

Pharmacological modulation of autophagy: Therapeutic potential and persisting obstacles

  • Lorenzo Galluzzi
  • , José Manuel Bravo-San Pedro
  • , Beth Levine
  • , Douglas R. Green
  • , Guido Kroemer
  • Cornell University
  • Université Paris Cité
  • Sorbonne Université
  • Centre de Recherche des Cordeliers
  • Institut national de la santé et de la recherche médicale
  • Université Paris-Sud
  • University of Texas Southwestern Medical Center
  • Howard Hughes Medical Institute
  • St. Jude Children Research Hospital
  • Karolinska Institutet
  • Assistance publique – Hôpitaux de Paris

Research output: Contribution to journalReview articlepeer-review

777 Scopus citations

Abstract

Autophagy is central to the maintenance of organismal homeostasis in both physiological and pathological situations. Accordingly, alterations in autophagy have been linked to clinically relevant conditions as diverse as cancer, neurodegeneration and cardiac disorders. Throughout the past decade, autophagy has attracted considerable attention as a target for the development of novel therapeutics. However, such efforts have not yet generated clinically viable interventions. In this Review, we discuss the therapeutic potential of autophagy modulators, analyse the obstacles that have limited their development and propose strategies that may unlock the full therapeutic potential of autophagy modulation in the clinic.

Original languageEnglish
Pages (from-to)487-511
Number of pages25
JournalNature Reviews Drug Discovery
Volume16
Issue number7
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Pharmacological modulation of autophagy: Therapeutic potential and persisting obstacles'. Together they form a unique fingerprint.

Cite this